Strange PR wording.....
“The treatment of mTNBC with leronlimab in this Phase 1b/2 trial is in addition to metastatic breast cancer (“MBC”) patients treated .”
MBC patients....I thought there was only one?
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-